Recently, Wang's research group from the Institute of Translational Medicine of Zhejiang Univers
READ MORE 2023-04-23Recently, Wang's research group from the Institute of Translational Medicine of Zhejiang Univers
READ MORE 2023-04-23On March 28, 2023, Kylo-0603, a thyroxine receptor-β (THR-β) agonist drug independently developed by
READ MORE 2023-04-09On March 15, 2023, the website of the Center for Drug Review and Evaluation (CDE) of the State Medic
READ MORE 2023-03-16Pfizer announced that the U.S. Food and Drug Administration (FDA) has granted priority review status
READ MORE 2023-02-23Scientists from the University of Illinois at Urbana-Champaign and other institutes found that PAC-1
READ MORE 2023-01-092022.12.12, the US FDA announced the approval of Mirati Therapeutics' oral KRAS G12C inhibitor a
READ MORE 2022-12-15Abbvie announced that the European Commission has approved a new indication for Skyrizi, its novel a
READ MORE 2022-11-25AstraZeneca (AstraZeneca) recently reported positive, high-level results from its phase II trial of
READ MORE 2022-10-28Beijing, Oct. 9, 2022 -- Bayer announced that the global initiative for state and drug administratio
READ MORE 2022-10-09On September 13, 2022, Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. and South Ko
READ MORE 2022-09-14We would like to use cookies to better understand your use of this website, which will help improve your experience on future visits to the website. You can change this setting in your browser settings. For more information about the use of cookies, please refer to our Privacy Policy.